CA2764351C - Stimulator of genital, sexual and reproductive function - Google Patents

Stimulator of genital, sexual and reproductive function Download PDF

Info

Publication number
CA2764351C
CA2764351C CA2764351A CA2764351A CA2764351C CA 2764351 C CA2764351 C CA 2764351C CA 2764351 A CA2764351 A CA 2764351A CA 2764351 A CA2764351 A CA 2764351A CA 2764351 C CA2764351 C CA 2764351C
Authority
CA
Canada
Prior art keywords
sexual
pro
heptapeptide
intranasal administration
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2764351A
Other languages
English (en)
French (fr)
Other versions
CA2764351A1 (en
Inventor
Nikolay Fedorovich Myasoedov
Alim Vasilievich Nemersky
Mikhail Alexandrovich Mogutov
Tatiyana Nikolaevna Sollertinskaya
Mstislav Vladilenovich Shoroshov
Dmitry Viktorovich Golikov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OVB Ireland Ltd
Original Assignee
Bio Peptid Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Peptid Co Ltd filed Critical Bio Peptid Co Ltd
Publication of CA2764351A1 publication Critical patent/CA2764351A1/en
Application granted granted Critical
Publication of CA2764351C publication Critical patent/CA2764351C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2764351A 2009-06-04 2010-06-01 Stimulator of genital, sexual and reproductive function Active CA2764351C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2009121281 2009-06-04
RU2009121281/15A RU2404793C1 (ru) 2009-06-04 2009-06-04 Стимулятор половой, сексуальной и репродуктивной функции
PCT/RU2010/000285 WO2010140926A1 (ru) 2009-06-04 2010-06-01 Стимулятор половой, сексуальной и репродуктивной функции

Publications (2)

Publication Number Publication Date
CA2764351A1 CA2764351A1 (en) 2010-12-09
CA2764351C true CA2764351C (en) 2016-08-16

Family

ID=43297916

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2764351A Active CA2764351C (en) 2009-06-04 2010-06-01 Stimulator of genital, sexual and reproductive function

Country Status (9)

Country Link
US (1) US8883741B2 (https=)
EP (1) EP2465521B1 (https=)
JP (1) JP5643816B2 (https=)
CN (1) CN102481335B (https=)
BR (1) BRPI1011071B8 (https=)
CA (1) CA2764351C (https=)
ES (1) ES2831673T3 (https=)
RU (1) RU2404793C1 (https=)
WO (1) WO2010140926A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2404793C1 (ru) 2009-06-04 2010-11-27 Общество с ограниченной ответственностью Био Пептид Стимулятор половой, сексуальной и репродуктивной функции
RU2507212C3 (ru) * 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" Способ получения рекомбинантного пептида и полученный пептид
JP6552960B2 (ja) * 2013-05-28 2019-07-31 アイビックス・リミテッドＩｖｉｘ Ｌｔｄ． 組換えペプチドを生産するための方法および得られるペプチド
US9717903B1 (en) 2015-03-17 2017-08-01 Gary Barrett Electronic process to restore, improve and/or strengthen the libido; method to mend the sex drive in males and females
RU2655763C2 (ru) * 2016-10-24 2018-05-29 Общество С Ограниченной Ответственностью "Айвикс" Фармацевтическая композиция и способ лечения женских сексуальных дисфункций
RU2626002C1 (ru) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" Новая группа пептидов для лечения женской сексуальной дисфункции
JP2018118973A (ja) * 2018-02-23 2018-08-02 アイビックス・リミテッドＩｖｉｘ Ｌｔｄ． 組換えペプチドを生産するための方法および得られるペプチド
JP6858227B2 (ja) * 2019-07-11 2021-04-14 アイビックス・リミテッドＩｖｉｘ Ｌｔｄ． 組換えペプチドを生産するための方法および得られるペプチド

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU1124544C (ru) * 1983-06-30 1995-01-09 Институт молекулярной генетики РАН Гептапептид, обладающий свойствами психостимулятора пролонгированного действия с иммунотропной активность
RU2058791C1 (ru) 1989-01-11 1996-04-27 Государственное предприятие "Элер-микро" Стимулятор репродуктивной способности у теплокровных животных
US5872100A (en) 1990-05-11 1999-02-16 Deghenghi; Romano Peptides containing D-2-Alkyl-Tryptophan
WO1994022460A1 (en) 1993-04-05 1994-10-13 University Patents, Inc. Diagnosis and treatment of erectile dysfunction
US5932548A (en) 1998-06-03 1999-08-03 Deghenghi; Romano Lysine containing peptides for treatment of heart disease
RU2155065C1 (ru) 1999-04-23 2000-08-27 Институт молекулярной генетики РАН Анксиолитическое средство и фармацевтическая композиция анксиолитического действия
US6211156B1 (en) 1999-11-10 2001-04-03 Asta Medica A.G. Peptides for treatment of erectile dysfunction
RU2252779C1 (ru) * 2003-09-23 2005-05-27 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Способ профилактики и лечения язв желудочно-кишечного тракта
RU2290195C1 (ru) * 2005-04-21 2006-12-27 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Средство с антикоагулянтной, антитромбоцитарной, антитромботической, фибриндеполимеризационной и фибринолитической активностями
RU2317099C1 (ru) * 2006-08-29 2008-02-20 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Лечебно-профилактическое средство для восстановления нарушений половых функций, способ получения масла зародышей пшеницы и способ получения концентрата масла зародышей пшеницы для восстановления нарушений половых функций
CN101302246B (zh) * 2007-05-09 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 黑色素皮质激素受体七肽类激动剂及其制备方法和用途
RU2404793C1 (ru) 2009-06-04 2010-11-27 Общество с ограниченной ответственностью Био Пептид Стимулятор половой, сексуальной и репродуктивной функции
EA013948B1 (ru) 2009-06-08 2010-08-30 Общество С Ограниченной Ответственностью "Витанта" Средство, активирующее половую функцию

Also Published As

Publication number Publication date
JP5643816B2 (ja) 2014-12-17
ES2831673T3 (es) 2021-06-09
CA2764351A1 (en) 2010-12-09
JP2012528856A (ja) 2012-11-15
BRPI1011071B1 (pt) 2020-10-20
EP2465521A1 (en) 2012-06-20
WO2010140926A1 (ru) 2010-12-09
EP2465521A4 (en) 2012-12-19
US8883741B2 (en) 2014-11-11
CN102481335B (zh) 2014-02-26
BRPI1011071B8 (pt) 2021-05-25
RU2404793C1 (ru) 2010-11-27
EP2465521B1 (en) 2020-10-14
CN102481335A (zh) 2012-05-30
BRPI1011071A2 (pt) 2016-09-27
US20120129791A1 (en) 2012-05-24

Similar Documents

Publication Publication Date Title
CA2764351C (en) Stimulator of genital, sexual and reproductive function
Kelley Sterility in the Female with Special Reference to Psychic Factors: Part I: A Review of the Literature
Noeggerath et al. Contributions to midwifery, and diseases of women and children
Rubovits et al. Intersexuality
Corner Corpus luteum therapy
Lewis The psychobiology of the castration reaction
Amador et al. A guide and resource directory to male fertility following spinal cord injury/dysfunction
Fry et al. The Family Good Health Guide: Common Sense on Common Health Problems
RU2612832C1 (ru) Способ создания стойкого венозного полнокровия в малом тазу у лабораторных животных
Novak Menstruation and Menstrual Disorders: Newer Concepts
Goldberg A glimpse into biblical and talmudic medicine
MARBACH et al. Psychosomatic aspects of infertility
Bandler The Expectant Mother
Welling et al. 11 The Adaptive Value of WomenTs Orgasm
Brackett et al. Male Fertility Following Spinal Cord Injury: A Guide For Patients
Craigie Case of Inflammation of the Adipose Tissue, Forming the Sheath of the Carotid Artery, Followed by Erosion and Perforation of the Arterial Tissue and Fatal Hemorrhage; with Some Remarks on the Peculiarities of Inflammation of the Adipose Tissue
Rebal Jr et al. Unusual sexual syndromes
BILLINGS Glandular therapy: introduction
PAT11O1OGY 1UESDAY, 1VI. IBRUAnY 2ND, 1S76.
Hanks ON THE CAUSES AND TREATMENT OF EXCESSIVE OR UNUSUAL UTERINE HEMORRHAGES, WITH ILLUSTRATIVE CASES
Atwater ANALYSIS OF ONE THOUSAND CASES OF MIDWIFERY IN THE PRIVATE PRACTICE
Vogt et al. Sexology
Heffernan Pituitrin in the Third Stage of Labor
Fowler are operating on the body politic, including the State
Weissman Neurovegetative system and uterine dynamics in labor: Perez, ML, and Rosenwasser, J.: Bol. Soc. chilena de obst. y ginec. 5: 95, 1940

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150601

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251020

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20260202

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260203